Female pattern hair loss: A pilot study investigating combination therapy with low-dose oral minoxidil and spironolactone
International Journal of Dermatology Dec 17, 2017
Sinclair RD, et al. - Researchers undertook an exploratory study of the efficacy of minoxidil 0.25 mg and spironolactone 25 mg for the treatment of patients pattern hair loss (PHL). It was inferred that once daily capsules containing minoxidil 0.25 mg and spironolactone 25 mg was safe and effective in the treatment of FPHL.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
